繁體
简体中文
繁體中文

Columbia Management Advisors, Inc. CLMB

等待開盤 08-23 09:30:00 美东时间

123.345

+5.695

+4.84%

华盛通華盛通
立即下載
  • 最 高125.00
  • 今 開118.78
  • 成交量 3.08万股
  • 最 低 118.78
  • 昨 收 117.65
  • 總市值 5.70亿
  • 52周最高 144.485
  • 市盈率 30.35
  • 換手率 0.67%
  • 52周最低 83.71
  • 委 比 66.67%
  • 總股本 461.72万
  • 歷史最高 144.485
  • 量 比 0.50
  • 振 幅 5.29%
  • 歷史最低 1.37
  • 每 手 1
  • 風險率 13.00%

個股概要

財務分析

公司資料

相關新聞

分紅派息

  • 分時圖
  • 日k
  • 周k
  • 月k

相關新聞

更多
  • Climb Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates

    Climb Bio reported Q2 2025 financial results, highlighting progress with its lead product budoprutug in clinical trials for immune thrombocytopenia (ITP), systemic lupus erythematosus (SLE), and primary membranous nephropathy (pMN). The company also announced plans to initiate a Phase 2 trial for pMN and a Phase 1 trial for the subcutaneous formulation of budoprutug. CLYM116, targeting IgA nephropathy (IgAN), is advancing toward clinical developm...

    08-12 11:00

  • Why Climb Global Solutions Stock Keeps Climbing?

    Climb stock is up over 240% since mid-2023, Adhishthana principles show a classic Phase 9 breakout. Here's what investors need to know next.

    07-29 20:17

  • 美股大行评级 | 潜在涨幅102.43%!Mobileye Global获Canaccord Genuity升目标价至30美元,维持"买入"评级

    今日重点评级关注:Canaccord Genuity:维持Mobileye Global"买入"评级,目标价从25美元升至30美元;巴克莱:维持TechnipFMC"超配"评级,目标价从45美元升至51美元

    07-28 09:33

  • Barrington Research Maintains Outperform on Climb Global Solutions, Maintains $136 Price Target

    Barrington Research analyst Vincent Colicchio maintains Climb Global Solutions (NASDAQ:CLMB) with a Outperform and maintains $136 price target.

    07-26 01:47

  • Climb Global Solutions Sets Second Quarter 2025 Conference Call for July 31, 2025 at 8:30 a.m. ET

    Climb Global Solutions will host a conference call on July 31, 2025, at 8:30 a.m. Eastern time to discuss its second-quarter 2025 financial results. Interested parties can join via toll-free numbers (800-225-9448 for U.S., 203-518-9708 for international) or webcast using the provided link. Questions can be submitted in advance to CLMB@elevate-ir.com. A replay will be available on the company’s website.

    07-17 12:30

  • Climb Channel Solutions Expands Bluebeam Portfolio with SiteDocs to Drive Safety and Compliance Innovation

    Climb Channel Solutions has integrated SiteDocs into its Bluebeam portfolio, enhancing its offerings for the architecture, engineering, and construction (AEC) industry. The addition of SiteDocs, a safety compliance platform, strengthens Climb's commitment to innovation, improving safety, efficiency, and compliance. This partnership combines Bluebeam's document management tools with SiteDocs' real-time safety solutions, providing a comprehensive a...

    07-16 11:00

  • Climb Channel Teams Up With Egnyte to Bring Secure Cloud Collaboration Tools to US Businesses

    Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ:CLMB) is proud to announce a distribution agreement with Egnyte, a leader in

    06-27 19:05

  • Climb Channel Solutions Announces Distribution Partnership with Egnyte

    Climb Channel Solutions, a global technology distributor and subsidiary of Climb Global Solutions, Inc., has announced a distribution agreement with Egnyte, a leader in secure content collaboration and governance. This partnership allows Climb to offer Egnyte's cloud-native platform to resellers and their customers across the U.S., supporting the expansion of transformative technologies worldwide. Egnyte's platform, which integrates cloud content...

    06-27 11:00

  • Climb Bio Appoints Edgar D. Charles, M.D., MSc as Chief Medical Officer

    Climb Bio appoints Dr. Edgar Charles as CMO and Cindy Driscoll as Senior Vice President, Finance. Dr. Charles brings over 20 years of experience in immunology-focused drug development, while Cindy has extensive financial leadership in biotech. Their expertise strengthens Climb Bio’s clinical programs for immune-mediated diseases, including budoprutug and CLYM116. Both executives received equity awards as part of their inducement packages.

    06-18 11:00

  • Climb Channel Solutions Announces North American Alliance with Bugcrowd

    Climb Channel Solutions has entered a new North American distribution agreement with Bugcrowd, a leading crowdsourced cybersecurity platform. This collaboration allows Climb to offer Bugcrowd’s security solutions, including vulnerability detection and penetration testing, to its extensive network of over 7,000 resellers. The partnership aims to address the growing need for proactive security measures in the face of evolving cyber threats. Both co...

    06-18 11:00